BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 27278109)

  • 1. Pharmaceutical cocrystals: walking the talk.
    Bolla G; Nangia A
    Chem Commun (Camb); 2016 Jun; 52(54):8342-60. PubMed ID: 27278109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
    Newman A; Reutzel-Edens SM; Zografi G
    J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs.
    Bolla G; Sarma B; Nangia AK
    Chem Rev; 2022 Jul; 122(13):11514-11603. PubMed ID: 35642550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocrystal and its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.
    Wang N; Xie C; Lu H; Guo N; Lou Y; Su W; Hao H
    Curr Pharm Des; 2018; 24(21):2339-2348. PubMed ID: 29788878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
    Panzade PS; Shendarkar GR
    Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy.
    Srivastava D; Fatima Z; Kaur CD
    Mini Rev Med Chem; 2018; 18(14):1160-1167. PubMed ID: 29512461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advancements in Pharmaceutical Cocrystals, Preparation Methods, and their Applications.
    Manchanda D; Kumar A; Nanda A
    Curr Pharm Des; 2021; 27(44):4477-4495. PubMed ID: 33858309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.
    Kuminek G; Cao F; Bahia de Oliveira da Rocha A; Gonçalves Cardoso S; Rodríguez-Hornedo N
    Adv Drug Deliv Rev; 2016 Jun; 101():143-166. PubMed ID: 27137109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical cocrystals: the coming wave of new drug substances.
    Brittain HG
    J Pharm Sci; 2013 Feb; 102(2):311-7. PubMed ID: 23192888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical Cocrystals as an Opportunity to Modify Drug Properties: From the Idea to Application: A Review.
    Sokal A; Pindelska E
    Curr Pharm Des; 2018; 24(13):1357-1365. PubMed ID: 29278209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocrystallization: Cutting Edge Tool for Physicochemical Modulation of Active Pharmaceutical Ingredients.
    Kumari N; Ghosh A
    Curr Pharm Des; 2020; 26(38):4858-4882. PubMed ID: 32691702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical cocrystals and poorly soluble drugs.
    Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
    Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical cocrystals: along the path to improved medicines.
    Duggirala NK; Perry ML; Almarsson Ö; Zaworotko MJ
    Chem Commun (Camb); 2016 Jan; 52(4):640-55. PubMed ID: 26565650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications.
    Guo M; Sun X; Chen J; Cai T
    Acta Pharm Sin B; 2021 Aug; 11(8):2537-2564. PubMed ID: 34522597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
    Malamatari M; Ross SA; Douroumis D; Velaga SP
    Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in Translational Development of Pharmaceutical Cocrystals.
    Kale DP; Zode SS; Bansal AK
    J Pharm Sci; 2017 Feb; 106(2):457-470. PubMed ID: 27914793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical salts/cocrystals of enoxacin with dicarboxylic acids: Enhancing in vitro antibacterial activity of enoxacin by improving the solubility and permeability.
    Liu L; Zou D; Zhang Y; Zhang Q; Feng Y; Guo Y; Liu Y; Zhang X; Cheng G; Wang C; Zhang Y; Zhang L; Wu L; Chang L; Su X; Duan Y; Zhang Y; Liu M
    Eur J Pharm Biopharm; 2020 Sep; 154():62-73. PubMed ID: 32645384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanochemical Approaches to Pharmaceutical Cocrystal Formation and Stability Analysis.
    Lin SY
    Curr Pharm Des; 2016; 22(32):5001-5018. PubMed ID: 27464722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical cocrystals: a rising star in drug delivery applications.
    Panzade P; Wagh A; Harale P; Bhilwade S
    J Drug Target; 2024 Dec; 32(2):115-127. PubMed ID: 38164658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.